Swissnex is bringing together two amazing cohorts of biotech and medtech startups from Switzerland. The Venture Leaders 2021 Swiss National Biotech Team will join in-person from Boston, and the Fall 2021 Innosuisse Internationalization Campers will join remotely from Switzerland.

11:00 am – Opening Remarks

11:05 am – Medtech Track

11:45 am – Break

11:50 am – Biotech Track

12:50 pm – Closing Remarks

Innosuisse Bootcampers:

• Anavo Medical – anavo medical uses cutting-edge nanotechnology to make seromas heal
  
• Synple Chem – Synple Chem has developed an automated, cartridge-based synthesis technology to enable chemists to accelerate their research.
• Hi-D Imaging – Hi-D Imaging is a platform that revolutionizes medical imaging processing by decreasing pre-operational/surgical planning times and overcoming limitations of medical scans for physicians for cardiovascular pre-operational planning.
• PeriVision – PeriVision uses AI & VR technology to make glaucoma care accessible and affordable for everyone.
• Sleepiz – Sleepiz AG uses millimeter-wave radar technology to enable patients to manage chronic disease under realistic in-home sleep conditions.
• Terapet – Terapet develops a novel medical device to bring proton therapy for cancer treatment to the next level.

Venture Leaders: 

• Abologix – ABOLOGIX is developing monoclonal antibodies against two novel biological targets
• Acthera – Acthera’s mechano-responsive, Hard-Shelled Liposomes (HSLs) can fill a mission-critical gap for targeted drug release in countless indications, enabling transformative therapeutic approaches and leverage the potential of available therapies.
• Alithea – Rapid RNA-seq for blood samples
• Avrion Therapeutics – Avrion Therapeutics is developing precision gene therapy solutions to address genetically defined neurological disorders.
• Cellvie – cellvie is bringing about a new treatment modality, leveraging the therapeutic potential of mitochondria.
• Gnubiotics  – Gnubiotics Sciences SA is revolutionizing the microbiome health of humans and animals with a new category of complex molecules.
• HexagonFab – HexagonFab has developed biological sensors for rapid and highly sensitive detection of biological substances like proteins, DNA, or small molecules, with portable and affordable readers.
• Nemosia – Nemosia, aims to raise public awareness of neurological disorders and promote a culture where it is seen as normal and safe to do regular brain check-ups.
• NexImmune – NextImmune intends to commence operations with screening and preclinical development of compounds that interfere with coronin 1-dependent T cell activation in autoimmune diseases and organ transplantation